Annual Non Current Assets
$73.88 M
-$6.39 M-7.96%
December 31, 2023
Summary
- As of February 7, 2025, RLAY annual long term assets is $73.88 million, with the most recent change of -$6.39 million (-7.96%) on December 31, 2023.
- During the last 3 years, RLAY annual non current assets has risen by +$44.15 million (+148.50%).
- RLAY annual non current assets is now -7.96% below its all-time high of $80.27 million, reached on December 31, 2022.
Performance
RLAY Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$64.99 M
-$3.29 M-4.82%
September 1, 2024
Summary
- As of February 7, 2025, RLAY quarterly long term assets is $64.99 million, with the most recent change of -$3.29 million (-4.82%) on September 1, 2024.
- Over the past year, RLAY quarterly non current assets has dropped by -$10.18 million (-13.54%).
- RLAY quarterly non current assets is now -20.19% below its all-time high of $81.42 million, reached on September 30, 2022.
Performance
RLAY Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
RLAY Non Current Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -8.0% | -13.5% |
3 y3 years | +148.5% | +100.8% |
5 y5 years | +1538.4% | - |
RLAY Non Current Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -8.0% | +129.4% | -20.2% | +101.8% |
5 y | 5-year | -8.0% | +148.5% | -20.2% | +124.8% |
alltime | all time | -8.0% | +1538.4% | -20.2% | +124.8% |
Relay Therapeutics Non Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $64.99 M(-4.8%) |
Jun 2024 | - | $68.28 M(-4.3%) |
Mar 2024 | - | $71.34 M(-3.4%) |
Dec 2023 | $770.10 M(-24.5%) | $73.88 M(-1.7%) |
Sep 2023 | - | $75.16 M(-3.2%) |
Jun 2023 | - | $77.67 M(-1.9%) |
Mar 2023 | - | $79.17 M(-1.4%) |
Dec 2022 | $1.02 B | $80.27 M(-1.4%) |
Sep 2022 | - | $81.42 M(+142.1%) |
Jun 2022 | - | $33.63 M(-1.4%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | $34.09 M(+5.9%) |
Dec 2021 | $976.24 M(+26.8%) | $32.20 M(-0.5%) |
Sep 2021 | - | $32.36 M(-2.3%) |
Jun 2021 | - | $33.13 M(+14.6%) |
Mar 2021 | - | $28.91 M(-2.7%) |
Dec 2020 | $770.10 M(+113.6%) | $29.73 M(-0.3%) |
Sep 2020 | - | $29.83 M(-7.3%) |
Jun 2020 | - | $32.17 M(+1.8%) |
Mar 2020 | - | $31.61 M(-2.8%) |
Dec 2019 | $360.54 M(-15.0%) | $32.53 M |
Dec 2018 | $424.10 M | - |
FAQ
- What is Relay Therapeutics annual long term assets?
- What is the all time high annual non current assets for Relay Therapeutics?
- What is Relay Therapeutics annual non current assets year-on-year change?
- What is Relay Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Relay Therapeutics?
- What is Relay Therapeutics quarterly non current assets year-on-year change?
What is Relay Therapeutics annual long term assets?
The current annual non current assets of RLAY is $73.88 M
What is the all time high annual non current assets for Relay Therapeutics?
Relay Therapeutics all-time high annual long term assets is $80.27 M
What is Relay Therapeutics annual non current assets year-on-year change?
Over the past year, RLAY annual long term assets has changed by -$6.39 M (-7.96%)
What is Relay Therapeutics quarterly long term assets?
The current quarterly non current assets of RLAY is $64.99 M
What is the all time high quarterly non current assets for Relay Therapeutics?
Relay Therapeutics all-time high quarterly long term assets is $81.42 M
What is Relay Therapeutics quarterly non current assets year-on-year change?
Over the past year, RLAY quarterly long term assets has changed by -$10.18 M (-13.54%)